FSMAX
Price
$102.72
Change
+$1.18 (+1.16%)
Updated
Oct 8 closing price
Net Assets
41.44B
PSKCX
Price
$44.96
Change
+$0.40 (+0.90%)
Updated
Oct 8 closing price
Net Assets
923.46M
Interact to see
Advertisement

FSMAX vs PSKCX

Header iconFSMAX vs PSKCX Comparison
Open Charts FSMAX vs PSKCXBanner chart's image
Fidelity Extended Market Index
Price$102.72
Change+$1.18 (+1.16%)
VolumeN/A
Net Assets41.44B
Virtus KAR Mid-Cap Growth C
Price$44.96
Change+$0.40 (+0.90%)
VolumeN/A
Net Assets923.46M
FSMAX vs PSKCX Comparison Chart in %
View a ticker or compare two or three
VS
FSMAX vs. PSKCX commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMAX is a Hold and PSKCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 41.4B vs. PSKCX (923M). FSMAX pays higher dividends than PSKCX: FSMAX (0.44) vs PSKCX (0.00). FSMAX was incepted earlier than PSKCX: FSMAX (14 years) vs PSKCX (25 years). PSKCX (2.04) is less costly to investors than FSMAX (0.04). PSKCX is a more actively managed with annual turnover of: 13.00 vs. FSMAX (9.00). FSMAX has a lower initial minimum investment than PSKCX: FSMAX (0) vs PSKCX (2500). FSMAX annual gain was more profitable for investors over the last year : 17.85 vs. PSKCX (0.38). FSMAX return over 5 years is better than : 50.18 vs. PSKCX (-7.88).
FSMAXPSKCXFSMAX / PSKCX
Total Expense Ratio0.042.042%
Annual Report Gross Expense Ratio0.042.042%
Fund Existence14 years25 years-
Gain YTD11.7300.5642,079%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets41.4B923M4,485%
Annual Yield % from dividends0.440.00-
Returns for 1 year17.850.384,660%
Returns for 3 years68.0032.30210%
Returns for 5 years50.18-7.88-637%
Returns for 10 years104.77152.0469%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FATE1.510.12
+8.63%
Fate Therapeutics
ALUR2.170.10
+4.83%
Allurion Technologies
PHAT11.050.21
+1.94%
Phathom Pharmaceuticals
ERIC8.540.11
+1.30%
Ericsson
EEFT86.53-0.39
-0.45%
Euronet Worldwide